keyword
MENU ▼
Read by QxMD icon Read
search

Transfusion Adverse Reactions

keyword
https://www.readbyqxmd.com/read/30325037/platelet-concentrate-supernatants-alter-endothelial-cell-mrna-and-protein-expression-patterns-as-a-function-of-storage-length
#1
Caroline Sut, Hind Hamzeh-Cognasse, Charles-Antoine Arthaud, Marie-Ange Eyraud, Kamel Chettab, Charles Dumontet, Sandrine Laradi, Thierry Burnouf, Olivier Garraud, Fabrice Cognasse
BACKGROUND: Platelet transfusions are safe but can nevertheless cause serious adverse reactions (SARs). This study investigated the effects of platelet biological response modifiers (BRMs) that accumulate during storage and are commonly associated with transfusion adverse reactions. STUDY DESIGN AND METHODS: Endothelial cells (ECs), that is, EA.hy926, were exposed in vitro to supernatants of platelet components (PCs) that had been either implicated or not in SARs...
October 16, 2018: Transfusion
https://www.readbyqxmd.com/read/30294786/international-validation-of-harmonized-definitions-for-complications-of-blood-donations
#2
Kevin J Land, Mary Townsend, Mindy Goldman, Barbee I Whitaker, Gabriela E Perez, Jo C Wiersum-Osselton
BACKGROUND: In December 2014, a multinational collaboration of hemovigilance experts from the International Society of Blood Transfusion (ISBT), the International Hemovigilance Network, and AABB published harmonized definitions of complications related to blood donation titled "Standard for Surveillance of Complications Related to Blood Donation." Both mandatory and optional terms were included. The definitions are endorsed by the Alliance of Blood Operators and the European Blood Alliance...
October 8, 2018: Transfusion
https://www.readbyqxmd.com/read/30291756/comparison-of-administration-of-platelet-concentrates-suspended-in-m-sol-or-brs-a-for-pediatric-patients
#3
Shunsuke Kojima, Ryu Yanagisawa, Miyuki Tanaka, Yozo Nakazawa, Shigetaka Shimodaira
BACKGROUND: Two different platelet additive solutions (PASs), M-sol and BRS-A, used in succession, have been reported as novel PASs in Japan. However, there are not enough clinical data comparing platelet concentrates (PCs) suspended in these PASs. STUDY DESIGN AND METHODS: A retrospective cohort study of consecutive cases was performed between 2013 and 2018. For the first 30 months, children with primary hematologic and/or malignant diseases were transfused resuspended PCs in M-sol (RPC-M) as plasma-replaced PCs...
October 6, 2018: Transfusion
https://www.readbyqxmd.com/read/30249532/apheresis-education-and-certification-for-nurses
#4
Kazuma Ikeda, Kenneth E Nollet, Hans Vrielink, Hitoshi Ohto
Hematopoietic stem cell transplantation requires a wide-range of expertise and procedural competence, in which nurses play important roles throughout, including stem cell mobilization and collection by apheresis. Little is published about post-licensure nursing education in apheresis, which suggests that it proceeds at the discretion of individual institutions, supplemented with practical training by equipment manufacturers. Information can be obtained on a small number of apheresis training courses for nurses in Australia, Canada, Indonesia, Italy, The Netherlands, Sweden and Turkey, and on nurse certification systems in Turkey and the United States...
September 11, 2018: Transfusion and Apheresis Science
https://www.readbyqxmd.com/read/30244510/autologous-blood-reinfusion-during-iatrogenic-acute-hemorrhagic-cardiac-tamponade-safety-and-feasibility-in-a-cohort-of-30-patients
#5
Luigi Fiocca, Alberto F Cereda, Chiara Bernelli, Paolo A Canova, Federica Serino, Tullio Niglio, Giuseppe Musumeci, Giulio Guagliumi, Angelina Vassileva, Michele Senni, Orazio Valsecchi
BACKGROUND: Iatrogenic hemorrhagic pericardial tamponade (IHPT) represents a life-threating condition requiring emergency pericardiocentesis. In this clinical context, reinfusion of pericardial blood can stabilize the patient and sustain hemodynamic conditions. AIMS AND METHODS: We reviewed all cases of IHPT occurred at our hospital over a 10 years span. In all patient autologous blood reinfusion through a femoral vein was performed. RESULTS: In our clinical experience of 30 consecutive patients with hemorrhagic cardiac tamponade, this technique was successful to limit blood transfusions, to prevent further clinical worsening and bridge patients with intractable bleeding, to cardiac surgery...
September 23, 2018: Catheterization and Cardiovascular Interventions
https://www.readbyqxmd.com/read/30229938/home-transfusion-three-decades-of-practice-at-a-tertiary-care-hospital
#6
Dora García, Ana Aguilera, Francisco Antolín, José-Luis Arroyo, Miguel Lozano, Pedro Sanroma, Iñigo Romón
BACKGROUND: Hospital at Home (HH) provides specialized care at the patients' homes. Keeping patients in familial surroundings can result in better outcomes reducing readmission to hospital, mortality, and costs of care. Home transfusion (HT) can be a key element in HH management but is scarcely deployed due to concerns about safety and cost. We have reviewed our HT practice to assess its feasibility and safety. STUDY DESIGN AND METHODS: We prospectively reviewed data collected from 1985 to 2015, focusing specially on feasibility and procedural safety, looking for adverse events of transfusion...
October 2018: Transfusion
https://www.readbyqxmd.com/read/30198955/hemofiltration-successfully-eliminates-severe-cytokine-release-syndrome-following-cd19-car-t-cell-therapy
#7
Yanfen Liu, Xinfeng Chen, Dao Wang, Hong Li, Jianmin Huang, Zhen Zhang, Yingjin Qiao, Hongling Zhang, Ying Zeng, Chao Tang, Shuangning Yang, Xiaochun Wan, Youhai H Chen, Yi Zhang
Cytokine release syndrome (CRS) remains to be a major adverse effect of chimeric antigen receptor T (CAR-T) cell therapy in B-cell acute lymphoblastic leukemia (B-ALL) and lymphoma. It was urgent to explore novel strategy for managing severe CRS. We conducted a clinical trial to assess the safety and efficacy of CD19-targeting CAR-T-cells in the treatment of relapsed and chemotherapy-refractory B-ALL and lymphoma. A 10-year-old boy with B-ALL who never achieved minimal residual disease (MRD) negative status after 5 courses of chemotherapy was enrolled into our study and received a total of 3...
November 2018: Journal of Immunotherapy
https://www.readbyqxmd.com/read/30197000/how-clinicians-can-minimize-transfusion-related-adverse-events
#8
C Aubron, P Aries, C Le Niger, R L Sparrow, Y Ozier
OBJECTIVES: Transfusion-related adverse events (TRAE) can contribute to patient morbidity and mortality. In this brief narrative review, the strategies that clinicians can apply at the bedside to avoid TRAE are discussed. METHODS: Strategies to avoid the following five types of TRAE were reviewed: transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), transfusion-associated hypothermia (TAH), transfusion-related allergic reactions (TRAR) and acute haemolytic transfusion reactions (AHTR)...
August 25, 2018: Transfusion Clinique et Biologique: Journal de la Société Française de Transfusion Sanguine
https://www.readbyqxmd.com/read/30178875/neutropenia-and-monocytopenia-in-recurrent-anaphylactoid-reactions-after-red-blood-cell-transfusions-in-a-woman-with-immunoglobulin-a-iga-deficiency-and-anti-iga
#9
Theodore E Warkentin, Pierre-Aurèle Morin, Nancy M Heddle
BACKGROUND: Transfusion-associated anaphylaxis has been associated with anti-immunoglobulin A (anti-IgA) of IgG class in patients with IgA deficiency. In recent years, however, the frequency and clinical impact of this syndrome has been questioned. We present a case of recurrent red blood cell (RBC) transfusion-associated anaphylactoid reactions (rigors, hypertension, transient monocytopenia, and neutropenia) associated with anti-IgA. CASE REPORT: An 88-year-old woman developed anemia after a traumatic right humerus fracture...
October 2018: Transfusion
https://www.readbyqxmd.com/read/30139570/how-to-mitigate-the-risk-of-inducing-transfusion-associated-adverse-reactions
#10
O Garraud, F Cognasse, S Laradi, H Hamzeh-Cognasse, T Peyrard, J-D Tissot, S Fontana
Transfusion has become extremely safe but can still be associated with adverse reactions. Some adverse reactions can be mitigated by applying measures to donor selection, the process of separating blood components as well as hospital-based procedures consisting in matching the donor and the recipient; special attention is given to optimizing the best fit between the component and the beneficiary, which is not only an immuno-hematological challenge (fresh versus old blood, testing for certain viruses such as CMV, parvovirus B19, etc...
July 27, 2018: Transfusion Clinique et Biologique: Journal de la Société Française de Transfusion Sanguine
https://www.readbyqxmd.com/read/30127562/-di-a-and-di-b-allele-frequencies-among-southern-thai-blood-donors
#11
Musleeha Chesor, Supattra Mitundee, Siriporn Nathalang, Phatchira Thattanon, Kamphon Intharanut, Pussadee Tobunluepop, Oytip Nathalang
Diego (DI) blood group genotyping is clinically important in Asian populations. Data of Diego blood type among southern Thais is still unknown. This study aimed to report DI*A and DI*B allele frequencies in southern Thai blood donors and to estimate potential risk of Dia incompatibility and alloimmunization in Thai populations. DNA samples obtained from 427 southern Thai blood donors were genotyped for DI*A and DI*B alleles by polymerase chain reaction with sequence-specific primer. DI*A and DI*B allele frequencies among southern Thais were 0...
July 2018: Indian Journal of Hematology & Blood Transfusion
https://www.readbyqxmd.com/read/30127560/comparative-efficacy-in-red-blood-cell-exchange-transfusions-with-different-apheresis-machines-in-patients-with-sickle-cell-disease
#12
Nurhilal Buyukkurt, Ilknur Kozanoğlu, Asli Pan Korur, Suheyl Asma, Mahmut Yeral, Soner Solmaz, Fatih Kandemir, Cigdem Gereklioglu, Cagla Sariturk, Can Boga, Hakan Ozdogu
The purpose of this study is to compare the efficacy and side effects of two red blood cell exchange (RBCX) transfusion systems in sickle cell disease (SCD). The data is collected retrospectively from the January 2010 to March 2015. 447 RBCX transfusions were performed to 165 patients. Side effects, clinical and technical efficacy were compared in between procedures with Cobe Spectra (CS) and Spectra Optia (SO) systems. Furthermore a subgroup analyses was performed for 40 patients who had RBCX transfusions with both system at least two times...
July 2018: Indian Journal of Hematology & Blood Transfusion
https://www.readbyqxmd.com/read/30124474/delayed-haemolytic-and-serologic-transfusion-reactions-pathophysiology-treatment-and-prevention
#13
Alexa J Siddon, Barton C Kenney, Jeanne E Hendrickson, Christopher A Tormey
PURPOSE OF REVIEW: The aim of this study was to summarize the basic epidemiology, pathophysiology and management of delayed serologic and delayed haemolytic transfusion reactions (DHTRs), as well as recent developments in our understanding of these adverse events. RECENT FINDINGS: Several studies have identified risk factors for DHTRs, including high alloantibody evanescence rates among both general patient groups and those with sickle cell disease (SCD). Antibody detection is also hampered by the phenomenon of transfusion record fragmentation...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30115655/cold-storage-of-platelets-in-additive-solution-the-impact-of-residual-plasma-in-apheresis-platelet-concentrates
#14
Irene Marini, Konstanze Aurich, Rabie Jouni, Stefanie Nowak-Harnau, Oliver Hartwich, Andreas Greinacher, Thomas Thiele, Tamam Bakchoul
Platelet transfusion became an indispensable therapy in the modern medicine. Although the clinical advantage of platelet transfusion is well established, adverse reactions upon transfusion, especially transmission of bacterial infection, still represent a major challenge. While bacterial contamination is favored by the storage of platelets at room temperature, cold storage may represent a solution for this clinically relevant issue. In this study, we aimed to elucidate whether plasma has protective or detrimental effects on cold-stored platelets...
August 16, 2018: Haematologica
https://www.readbyqxmd.com/read/30105510/a-randomized-controlled-trial-of-lusutrombopag-in-japanese-patients-with-chronic-liver-disease-undergoing-radiofrequency-ablation
#15
Ryosuke Tateishi, Masataka Seike, Masatoshi Kudo, Hideyuki Tamai, Seiji Kawazoe, Takayuki Katsube, Toshimitsu Ochiai, Takahiro Fukuhara, Takeshi Kano, Katsuaki Tanaka, Mineo Kurokawa, Kazuhide Yamamoto, Yukio Osaki, Namiki Izumi, Michio Imawari
BACKGROUND: Thrombocytopenia represents an obstacle for invasive procedures in chronic liver disease (CLD) patients. We aimed to estimate the appropriate dose and evaluate the efficacy and safety of lusutrombopag for the treatment of thrombocytopenia before percutaneous liver radiofrequency ablation (RFA) for primary hepatic cancer in patients with CLD. METHODS: In this multicenter, randomized, double-blind, placebo-controlled study conducted in Japan, 61 CLD patients with platelet count < 50 × 103 /µL at screening were randomized to placebo or lusutrombopag 2, 3, or 4 mg once daily for 7 days, followed by a 28-day post-treatment assessment period...
August 13, 2018: Journal of Gastroenterology
https://www.readbyqxmd.com/read/30078740/pre-operative-autologous-blood-donation-and-transfusion-related-adverse-reactions-a-14-year-experience-at-a-university-hospital
#16
Yoshiaki Furuta, Yuki Nakamura, Miho Tokida, Kayoko Ichikawa, Toshiya Ohsawa, Mitsuo Ohkubo, Akimichi Ohsaka
OBJECTIVE: The objective of this study was to determine the rate of adverse reactions to pre-operative autologous blood donation (PAD) transfusion in a single institution over a 14-year period. STUDY DESIGN AND METHODS: Between January 2003 and December 2016, we investigated adverse reactions to PAD transfusion and compared them with those to allogeneic blood transfusion in Juntendo University Hospital. Adverse reactions were categorized according to the definition proposed by the International Society of Blood Transfusion (ISBT) Working Party on Haemovigilance...
August 1, 2018: Transfusion and Apheresis Science
https://www.readbyqxmd.com/read/30073665/colloids-versus-crystalloids-for-fluid-resuscitation-in-critically-ill-people
#17
REVIEW
Sharon R Lewis, Michael W Pritchard, David Jw Evans, Andrew R Butler, Phil Alderson, Andrew F Smith, Ian Roberts
BACKGROUND: Critically ill people may lose fluid because of serious conditions, infections (e.g. sepsis), trauma, or burns, and need additional fluids urgently to prevent dehydration or kidney failure. Colloid or crystalloid solutions may be used for this purpose. Crystalloids have small molecules, are cheap, easy to use, and provide immediate fluid resuscitation, but may increase oedema. Colloids have larger molecules, cost more, and may provide swifter volume expansion in the intravascular space, but may induce allergic reactions, blood clotting disorders, and kidney failure...
August 3, 2018: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/30067867/red-blood-cell-transfusion-to-treat-or-prevent-complications-in-sickle-cell-disease-an-overview-of-cochrane-reviews
#18
REVIEW
Patricia M Fortin, Sally Hopewell, Lise J Estcourt
BACKGROUND: Globally, sickle cell disease (SCD) is one of the commonest severe monogenic disorders, due to the inheritance of two abnormal haemoglobin (beta globin) genes. SCD can cause severe pain, significant end-organ damage, pulmonary complications, and premature death. Red blood cell (RBC) transfusions are used to treat complications of SCD, e.g. acute chest syndrome (ACS) (this often involves a single transfusion episode), or they can be part of a regular long-term transfusion programme to prevent SCD complications...
August 1, 2018: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/30034477/acute-hemolytic-transfusion-reaction-in-group-b-recipient-associated-with-group-a-apheresis-platelet-donor-case-report-and-literature-review
#19
Tracy R Shachner, Christopher T Clark
Acute hemolytic transfusion reaction is a known but rare potential adverse event related to platelet transfusion. Most reported cases of platelet-related hemolytic transfusion reaction have resulted from transfusion of platelets from group O donor to group A recipient. We identified only one prior case report in the literature of hemolytic transfusion reactions resulting from transfusion of apheresis platelets from group A donor to group B recipient. In that case report, two platelet units were obtained from a single donation and transfused into two separate patients...
2018: Case Reports in Medicine
https://www.readbyqxmd.com/read/29957715/increasing-evidence-based-interventions-in-patients-with-acute-infections-in-a-resource-limited-setting-a-before-and-after-feasibility-trial-in-gitwe-rwanda
#20
Olivier Urayeneza, Pierre Mujyarugamba, Zacharie Rukemba, Vincent Nyiringabo, Polyphile Ntihinyurwa, John I Baelani, Arthur Kwizera, Danstan Bagenda, Mervyn Mer, Ndidiamaka Musa, Julia T Hoffman, Ashok Mudgapalli, Austin M Porter, Niranjan Kissoon, Hanno Ulmer, Lori A Harmon, Joseph C Farmer, Martin W Dünser, Andrew J Patterson
OBJECTIVE: To evaluate whether a focused education program and implementation of a treatment bundle increases the rate of early evidence-based interventions in patients with acute infections. DESIGN: Single-center, prospective, before-and-after feasibility trial. SETTING: Emergency department of a sub-Saharan African district hospital. PATIENTS: Patients > 28 days of life admitted to the study hospital for an acute infection...
August 2018: Critical Care Medicine
keyword
keyword
168409
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"